Protein Kinase D1 Inhibits Cell Proliferation Through Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Secretion in Prostate Cancer

Overview

Journal Cancer Res

Specialty Oncology

Date 2010 Feb 18

PMID 20160036

Citations 33

Authors

M Helal Uddin Biswas

Cheng Du

Chuanyou Zhang

Juerg Straubhaar

Lucia R Languino

K C Balaji

Affiliations

Soon will be listed here.

Abstract

We and others previously showed that protein kinase D1 (PKD1) is downregulated in several cancers including prostate; interacts with E-cadherin, a major cell adhesion epithelial protein; and causes increased cell aggregation and decreased motility of prostate cancer cells. In this study, we show that PKD1 complexes with beta3-integrin, resulting in activation of mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase-ERK pathway, which causes increased production of matrix metalloproteinase (MMP)-2 and MMP-9, that is associated with shedding of soluble 80 kDa E-cadherin extracellular domain. Interestingly, decreased cell proliferation following PKD1 transfection was rescued by MMP-2 and MMP-9 inhibitors and augmented by recombinant MMP-2 (rMMP-2) and rMMP-9 proteins, suggesting an antiproliferative role for MMPs in prostate cancer. Translational studies by in silico analysis of publicly available DNA microarray data sets show a significant direct correlation between PKD1 and MMP-2 expression in human prostate tissues. The study shows a novel mechanism for antiproliferative effects of PKD1, a protein of emerging translational interest in several human cancers, through increased production of MMP-2 and MMP-9 in cancer cells.

Citing Articles

miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer.

Asante D, Sreekumar A, Nathani S, Lee T, Sharma A, Patel N Cancers (Basel). 2024; 16(1).

PMID: 38201476 PMC: 10777946. DOI: 10.3390/cancers16010048.

Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.

Lu H, Cao L, Ballout F, Belkhiri A, Peng D, Chen L Gut. 2023; 73(1):47-62.

PMID: 37734913 PMC: 10872865. DOI: 10.1136/gutjnl-2023-329455.

Potential role for protein kinase D inhibitors in prostate cancer.

Chalfant V, Riveros C, Singh P, Shukla S, Balaji N, Balaji K J Mol Med (Berl). 2023; 101(4):341-349.

PMID: 36843036 DOI: 10.1007/s00109-023-02298-4.

Protein Kinase D2 and D3 Promote Prostate Cancer Cell Bone Metastasis by Positively Regulating Runx2 in a MEK/ERK1/2-Dependent Manner.

Roy A, Prasad S, Chen Y, Chao Y, Liu Y, Zhao J Am J Pathol. 2023; 193(5):624-637.

PMID: 36740185 PMC: 10155267. DOI: 10.1016/j.ajpath.2023.01.004.

Golgi Complex: A Signaling Hub in Cancer.

Spano D, Colanzi A Cells. 2022; 11(13).

PMID: 35805075 PMC: 9265605. DOI: 10.3390/cells11131990.

References

Witty J, Lempka T, Coffey Jr R, Matrisian L . Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res. 1995; 55(7):1401-6. View

Munshi H, Stack M . Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 2006; 25(1):45-56. DOI: 10.1007/s10555-006-7888-7. View

Takeha S, Fujiyama Y, Bamba T, Sorsa T, Nagura H, Ohtani H . Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect. Jpn J Cancer Res. 1997; 88(1):72-81. PMC: 5921245. DOI: 10.1111/j.1349-7006.1997.tb00304.x. View

Cauwe B, Van den Steen P, Opdenakker G . The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol. 2007; 42(3):113-85. DOI: 10.1080/10409230701340019. View

Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K . Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 2007; 67(17):8198-206. DOI: 10.1158/0008-5472.CAN-07-0607. View

Jaggi M, Rao P, Smith D, Hemstreet G, Balaji K . Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun. 2003; 307(2):254-60. DOI: 10.1016/s0006-291x(03)01161-6. View

Lokeshwar B . MMP inhibition in prostate cancer. Ann N Y Acad Sci. 1999; 878:271-89. DOI: 10.1111/j.1749-6632.1999.tb07690.x. View

Lopez-Otin C, Matrisian L . Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 2007; 7(10):800-8. DOI: 10.1038/nrc2228. View

Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

10.

Wielockx B, Lannoy K, Shapiro S, Itoh T, Itohara S, Vandekerckhove J . Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med. 2001; 7(11):1202-8. DOI: 10.1038/nm1101-1202. View

11.

Frisch S, Ruoslahti E . Integrins and anoikis. Curr Opin Cell Biol. 1997; 9(5):701-6. DOI: 10.1016/s0955-0674(97)80124-x. View

12.

Protheroe A, Banks R, Mzimba M, Porter W, Southgate J, Singh P . Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. Br J Cancer. 1999; 80(1-2):273-8. PMC: 2363021. DOI: 10.1038/sj.bjc.6690351. View

13.

Du C, Jaggi M, Zhang C, Balaji K . Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res. 2009; 69(3):1117-24. DOI: 10.1158/0008-5472.CAN-07-6270. View

14.

Balbin M, Fueyo A, Tester A, Pendas A, Pitiot A, Astudillo A . Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet. 2003; 35(3):252-7. DOI: 10.1038/ng1249. View

15.

Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O . Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem. 2000; 276(7):4972-80. DOI: 10.1074/jbc.M006102200. View

16.

Alexander C, Howard E, Bissell M, Werb Z . Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol. 1996; 135(6 Pt 1):1669-77. PMC: 2133964. DOI: 10.1083/jcb.135.6.1669. View

17.

Kuefer R, Hofer M, Gschwend J, Pienta K, Sanda M, Chinnaiyan A . The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin Cancer Res. 2003; 9(17):6447-52. View

18.

Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S . Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 1995; 182(6):1777-83. PMC: 2192231. DOI: 10.1084/jem.182.6.1777. View

19.

Liu E, Thant A, Kikkawa F, Kurata H, Tanaka S, Nawa A . The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1. Cancer Res. 2000; 60(9):2361-4. View

20.

Jaggi M, Du C, Zhang W, Balaji K . Protein kinase D1: a protein of emerging translational interest. Front Biosci. 2007; 12:3757-67. DOI: 10.2741/2349. View